Brief Descriptiom
This field-leading biotech company worked with major pharmaceutical and biotechnology companies to produce data on target engagement, toxicity and disease progression to accelerate drug development and reduce the overall costs and risks. The pathway-based drug discovery and development company was founded to identify active drug candidates preclinically and confirm their therapeutic activity. The company helped in expediting the drug development process and provided real-time insight into conditions including metabolic disorders, cancer, and diseases of inflammation and neurodegeneration.
Timeline
- 2001. Company founded
Inventor
Marc Hellerstein